
Heron Therapeutics Announces Appointment Of Mark Hensley As Chief Operating Officer
(MENAFN- PR Newswire) CARY, N.C., April 28, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX ) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as …